Prestige Brands Holdings Earnings Preview: Can This Streak Continue?

Prestige Brands Holdings (NYSE:PBH) will report earnings before markets open on Thursday, May 16th. Prestige Brands Holdings Inc. sells brand name over-the-counter drug, household cleaning and personal care products. The company’s products include Chloraseptic Clear eyes, Compound W, Murine, Little Remedies, New Skin, Comet, Spic and Span, Cutex, Denorex. The products are sold through multiple channels, including mass merchants and drug, grocery, dollar and club stores.

Here is your Cheat Sheet to Prestige Brands Holdings Earnings:

Earnings Expectations: Analysts expect earnings of $0.35 per share on revenues of $157.81 million. Currently, the company’s P/E ratio stands at 31.65.

Analyst Trends:

Analysts have a more negative outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings has fallen from a profit of $0.4 to a profit $0.39. For the current year, the average estimate is a profit of $1.49, which is better than the estimate ninety days ago.

Earnings Trends:

Here’s how Prestige Brands Holdings has been performing on an annual basis:

Fiscal Year 2008 2009 2010 2011 2012
Revenue ($) in millions 326.60 303.15 292.60 336.51 441.08
Diluted EPS ($) 0.68 -3.74 0.64 0.58 0.73

Next, our CHEAT SHEET investing framework asks us to drill down to the recent quarterly data:

Quarter Dec. 31, 2011 Mar. 31, 2012 Jun. 30, 2012 Sep. 30, 2012 Dec. 31, 2012
Revenue ($) in millions 106.25 134.00 147.00 161.86 160.23
Diluted EPS ($) 0.19 -0.0003 0.29 0.38 0.24

Past Performance:
Prestige Brands Holdings has beat analyst estimates 4 times in the past four quarters. Shareholders could expect a boost if the company beats estimates.

“E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our successful CHEAT SHEET investing framework. Don’t waste another minute – click here to discover our CHEAT SHEET stock picks now!

(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at]